Next Article in Journal
Echocardiographic Determination of Percutaneous Central Venous Catheters in the Superior Vena Cava: A Prospective Cohort Study
Previous Article in Journal
Urinary Protein Array Analysis to Identify Key Inflammatory Markers in Children with IgA Vasculitis Nephritis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Children
Volume 9
Issue 5
10.3390/children9050623
children-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Maternal Stress, Early Life Factors and Infant Salivary Cortisol Levels

by
Caroline-Aleksi Olsson Mägi
1,2,*,
Åshild Wik Despriee
3,4,
Milada Cvancarova Småstuen
4,
Catarina Almqvist
2,5,
Fuad Bahram
6,
Egil Bakkeheim
7,
Anders Bjerg
1,8,
Kari Glavin
4,
Berit Granum
9,
Guttorm Haugen
3,10,
Gunilla Hedlin
1,2,
Christine Monceyron Jonassen
11,12,
Karin C. Lødrup Carlsen
3,7,
Eva Maria Rehbinder
13,
Leif-Bjarte Rolfsjord
7,14,
Anne Cathrine Staff
3,10,
Håvard Ove Skjerven
3,7,
Riyas Vettukattil
3,7,
Björn Nordlund
1,2 and
Cilla Söderhäll
1,2
1
Department of Women’s and Children’s Health, Karolinska Institutet, SE-171 77 Stockholm, Sweden
2
Astrid Lindgren Children’s Hospital, Karolinska University Hospital, SE-171 64 Stockholm, Sweden
3
Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, NO-0424 Oslo, Norway
4
Faculty of Health, VID Specialized University, NO-0424 Oslo, Norway
5
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-171 77 Stockholm, Sweden
6
Research Centre, Stockholm South General Hospital, SE-118 83 Stockholm, Sweden
7
Division of Paediatric and Adolescent Medicine, Oslo University Hospital, NO-0424 Oslo, Norway
8
Martina Children’s Hospital, SE-114 86 Stockholm, Sweden
9
Department of Chemical Toxicology, Norwegian Institute of Public Health, NO-0213 Oslo, Norway
10
Division of Obstetrics and Gynaecology, Oslo University Hospital, NO-0424 Oslo, Norway
11
Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, NO-1430 Ås, Norway
12
Genetic Unit, Centre for Laboratory Medicine, Østfold Hospital Trust, NO-1714 Kalnes, Norway
13
Department of Dermatology and Vaenerology, Oslo University Hospital, NO-0424 Oslo, Norway
14
Department of Paediatric and Adolescent Medicine Elverum, Innlandet Hospital Trust, NO-2381 Brumunddal, Norway
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Author to whom correspondence should be addressed.
Children 2022, 9(5), 623; https://doi.org/10.3390/children9050623
Submission received: 28 February 2022 / Revised: 9 April 2022 / Accepted: 20 April 2022 / Published: 27 April 2022
Browse Figures
Review Reports Versions Notes

Abstract

:
Background: Salivary cortisol (SC), a commonly used biomarker for stress, may be disrupted by negative events in pregnancy, at birth and in infancy. We aimed to explore if maternal perceived stress (PSS) in or after pregnancy and SC levels in pregnancy were associated with SC in early infancy, and, secondly, to identify early life factors associated with infants’ SC levels (iSC). Methods: At 3 months of age, SC was analyzed in 1057 infants participating in a Nordic prospective mother-child birth cohort study. Maternal PSS was available from questionnaires at 18- and 34-week gestational age (GA) and 3-month post-partum, and SC was analyzed at 18-week GA. Early life factors included sociodemographic and infant feeding from questionnaires, and birth data from medical charts. Associations to iSC were analyzed by Spearman correlation and multinomial logistic regression analyses. Results: In this exploratory study neither PSS at any time point nor maternal SC (mSC) were associated with iSC. Higher birth weight was associated with higher levels of iSC, while inverse associations were observed in infants to a mother not living with a partner and mixed bottle/breastfeeding. Conclusions: Maternal stress was not associated with iSC levels, while birth weight, single motherhood and infant feeding may influence iSC levels.

1. Introduction

Salivary cortisol (SC) is a commonly used biomarker for stress in infants and children [1,2,3]. An association between maternal and infant saliva cortisol (iSC) levels has been observed in the early post-partum period and the infants’ first months in life [3,4], independent of sampling time of the day [5]. In adults and children, SC levels peak to their highest level after awakening, reflecting the cortisol awakening response (CAR) [6]. In infancy, CAR is not yet fully presented. The suggested maturation of CAR in infants is seen as a decrease in SC levels towards the evening, which usually occurs before 12 months of age [7].
In shared activities during the first year between mother and infant (e.g., breastfeeding and skin-to-skin care), SC levels can fluctuate in the infant and covary between the two [3,8]. Negative events in pregnancy can disrupt this covariation between mother and infant, leading to dyadic dysregulation and elevated iSC levels [9]. Psychological stressors to the infant have resulted in no to a small increase in iSC levels [10,11], whilst physical stressors have resulted in increased iSC levels [11]. In a case-control study of excessively crying infants, parents, but not their infants 0–5 months of age, had lower hair cortisol levels compared to controls [12], while the possible implication for infant stress of colic is not clear. We recently found that 26% of three months old infants from the general population-based Preventing Atopic Dermatitis and ALLergies in children (PreventADALL) cohort were perceived by their parents to have colic, abdominal pain or other discomforts [13], and this is thus a relatively common potential risk factor for stress. Fetal exposure to maternal stress in pregnancy (elevated plasma cortisol and psychosocial stress) may affect the regulation of infant stress and behavioral recovery after birth [14] and subsequently the maternal–infant bonding process [15]. Maternal perceived stress during pregnancy has also been suggested as a predictor of infant cortisol reactivity after birth and by 10 months of age [16]. In a recent study, we reported that 13–15% of women in the PreventADALL general population-based study experienced perceived high stress in mid- and late pregnancy [17]. However, possible associations between pregnancy-related factors, including maternal perceived stress and maternal saliva cortisol (mSC), birth-related factors, maternal stress post-partum or infant factors and early iSC levels in the general population are not well elucidated.
The aims of this exploratory study were to analyze the associations between maternal perceived stress during pregnancy and postpartum as well as pregnancy mSC levels and iSC levels at three months of age, and secondly to identify early life factors in pregnancy, at birth and in infancy that are associated with iSC levels at three months of age.

2. Materials and Methods

The women and infants in the present study are participants in the multicenter interventional birth cohort study PreventADALL (Preventing Atopic Dermatitis and ALLergy in children), conducted at the Oslo University Hospital and the Østfold Hospital Trust, Oslo, Norway; and Karolinska University Hospital, Stockholm, Sweden [18]. The PreventADALL study has two main objectives: to determine if allergic diseases may be prevented by skin and/or food interventions in infancy; and to identify factors early in life involved in non-communicable disease development. The present exploratory study adheres to the latter objective. Briefly, non-selected pregnant women from the general population were recruited antenatally between December 2014 and November 2016 at the routine ultrasound pregnancy screening at 18 weeks in mid-trimester (16–22 weeks gestational age), providing singleton or twin pregnancies and sufficient language skills (Norwegian or Swedish). Exclusion criteria were planning to move from the study area, severe maternal disease and pregnancies with three or more fetuses. Their infants were included at birth. Exclusion criteria also included severe neonatal disease and infant born before gestational week 35. Informed consent forms were signed by the women at enrolment and by both parents at birth. PreventADALL was registered at Clinical Trial Registration: ClinicalTrials.gov number: NCT02449850. Ethical approval was granted by the Regional Committee for Medical and Health Research Ethics in Norway, 8 December 2014 (2014/518) and the Swedish Ethical Review Authority, Sweden, 25 March 2015 (former Regional Ethics committee in Stockholm) (2014/2242-31/4).

2.1. Data Collection

At enrolment, a short interview was performed, height, weight and blood pressure were measured, a blood sample was drawn and a home saliva sampling kit was provided to the pregnant women. Electronic questionnaires were distributed twice in pregnancy; first at enrolment and the second around pregnancy week 34, based largely on questionnaires used in previous birth cohort studies [19,20,21]. The newborn infants of the participating mothers were included within the first 24 h after birth, with renewed informed consent by both parents. Electronic questionnaires at three months of age of the infant were completed by the mother. All completed questionnaires were submitted electronically and data stored at the University of Oslo, University Centre for Information Technology (USIT), Oslo, Norway.
From the 2697 pregnant women and their 2397 newborns enrolled in the PreventADALL study, three withdrew their consent, leaving 2394 mother-child pairs, whereof 2131 infants attended the three-month clinical examination. In the present study we included all 1057 infants who had available iSC measurement from saliva samples collected at three months of age (Figure 1).

2.2. Saliva Sampling and Cortisol Measurements

Home sampling kits were distributed at inclusion in pregnancy for maternal saliva sampling and at the three-month follow-up visit for infant saliva sampling. All kits included sampling instructions, a zip-locked plastic bag, a saliva kit (Salimetrics®, Carlsbad, CA, USA), a form to fill out the sampling time and date and prepaid addressed envelope to the study center (in Oslo for the Norwegian participants and in Stockholm for the Swedish participants). Parents were instructed to collect saliva within the next days, preferably on Monday, Tuesday or Wednesday, shortly after their own or the infant’s awakening (after 06.00) and before food/breastfeeding or water intake. The sample was refrigerated and mailed to the study center as soon as possible. Cortisol concentrations have previously shown stability in the postal service and to exposure to different temperatures [22,23]. Upon arrival, samples were registered and stored in −80 °C until analyzed.
Cortisol quantification was made with Radioimmunoassay (RIA), according to the manufacturer’s instructions, with CORT-CT2 kits from Cisbio Bioassays (Codolet, France) at Forskningscentrum (Södersjukhuset, Stockholm, Sweden) [24]. Salivary cortisol level was presented as nmol/L. The standard curve for SC measurement was 0.5–105 nmol/L. The standard procedure was to re-run all samples with a concentration higher than 110 nmol/L and dilute two-five times until concentrations were within the range of the standard curve. According to the manufacturer, the intra-assay precision of duplicates of saliva samples is CV (%) = 3.3 and inter-assay precision CV (%) = 8.4 (at Forskningscentrum, Södersjukhuset, Stockholm the intra-assay CV (%) = 5.13 and inter-assay CV (%) = 6.8).
Infant SC samples with a stated sampling time were collected between 02 AM and 9 PM (Supplementary Figure S1). The main outcome for PSS and mSC correlation with iSC was iSC levels at three months of age given as nmol/L (regardless of sampling time), while quartiles of iSC (nmol/L) were used as the main outcome to explore early life factors in the same infants. SC were categorised for sensitivity analyses by sampling time; morning sampling (from 05.00–10.59); other sampling time (11.00–04.59) or missing sampling time.

2.3. Perceived Stress

Information on maternal stress was included in the electronic questionnaires and was measured with Cohen’s Perceived Stress Scale (PSS) (14 items), which scores from 0 to 4 for each of the 14 items with a total maximum score of 56 [25], and measures how often in the past month one’s life was “unpredictable, uncontrollable or overloaded” [25]. PSS has been validated in the Swedish language [26]. A higher score indicates higher perceived stress. With no universally accepted cut-off value for high stress, we used the value identified in a previous report from the PreventADALL study with high perceived stress defined by a score of 29 or higher [17].

2.4. Possible Factors Associated with Infant Saliva Cortisol

Early life factors collected through the electronic questionnaire in mid-pregnancy, included socio-demographic information, previous and current health and maternal stress, while information about the father and socio-demographic, health or disease changes in the mother since inclusion was captured in the 34-week GA questionnaire. The information included mothers not living with a partner; e.g., women who lived alone, divorced, widow, other, low maternal education (maximum 9/10-year school or high school), maternal age at inclusion and if it was the first pregnancy or the mother had previous deliveries (alive or still-born).
Birth-related factors were collected from the maternal and infant birth records and by PreventADALL study personnel at the inclusion visit of the infant. Induced labor was defined as a medically induced labor. Vaginal birth included unassisted and births assisted birth with forceps or vacuum extraction. Cesarean section included planned elective and acute cesarean section. Birth weight was the infant’s first recorded weight.
Infant factors included exclusively breastfed and mixed feeding by bottle and breastfeeding (mixed fed) as well as colic, abdominal pain and pain or other discomforts reported at three months of age based on the following question: “In the last three months, did the infant have any of following?” [13]. Furthermore, as participation in a randomized clinical trial with skin, and/or food interventions may be cumbersome, we included group allocation to one of four groups to which infants were randomized at birth; skin intervention (regular skin emollients by oil baths and facial cream at least five times per week from two weeks of age), food intervention (introduction of four allergenic foods from three months of age, alas not started at the time of data collection), skin and food intervention or no intervention, described in detail elsewhere [18,27]. Mothers who reported any smoking or use of snus (moist snuff) after birth were categorized as using nicotine.

2.5. Statistical Analysis

Infant SC levels included some outliers (data were positively skewed). Thus, descriptive statistics are presented with median, interquartile range (IQR) or minimum-maximum (min-max) (continuous variables) and counts and percentages (%) (categorical variables). Spearman non-parametric correlations were used to describe correlations between infant SC levels and maternal PSS and SC levels and are presented with Spearman’s coefficient rho (r) and p-value.
To explore early life factors that may be associated with iSC levels (regardless of sampling time or missing sampling time), multinomial logistic regression was used. Infant SC data were divided in four equally large groups ≤5.50 nmol/L (n = 266), 5.51–15.35 nmol/L (n = 263), 15.36–24.93 nmol/L (n = 265) and ≥24.94 nmol/L (n = 263). In the univariate and multivariate multinomial logistic regression models, the group with the lowest iSC levels (≤5.50 nmol/L) was used as the reference category. Variables with p-value less than 0.1 from univariate analyses (Supplementary Table S1) were included in the multivariate multinomial regression models as covariates, and the results are presented as odds ratios (OR) with 95% confidence intervals (95% CI) and p-value. Significance for the level in multivariate regression models was set at 0.05. All analyses were considered exploratory, thus no correction for multiple testing was performed.
In the Supplementary Materials, Mann–Whitney U-test of factors possibly associated with iSC, using the entire study sample (Supplementary Table S2) as well as stratified by boys and girls (Supplementary Table S3), are presented as number, percent (%), median, inter-quartile range (IQR). T-test of included and not included infants is presented in Supplementary Table S4. Analyses were performed using SPSS statistics version 26 (IBM, Chicago, IL, USA).

3. Results

The 1057 included infants were similar to infants without available iSC samples (GA, age at saliva sampling, weight and maternal PSS) at three months of age and had a median age of 14 weeks and 51.4% were boys (Table 1). The overall median SC level was 15.30 nmol/L (IQR 15.35) (Table 1). Stratified by time of sampling, the median iSC levels were 14.00 nmol/L (IQR 13.40) among morning samples (n = 551), 13.20 nmol/L (IQR 16.1) in the 79 with other sampling time and 17.70 nmol/L (IQR 18.30) in the 427 infants with missing sampling time (Figure 2).
Maternal PSS was not significantly associated with iSC, neither by PSS in mid-trimester, third trimester or postnatally, nor among all infants (main outcome) or by sampling time (Table 2).
Maternal SC levels in mid-pregnancy was not significantly associated with iSC levels among all infants, nor among infants with morning sampling (Table 2). Further, mSC levels in mid-pregnancy were not associated with maternal PSS in mid-pregnancy, last trimester or postnatally (Supplementary Table S5).
Associations between early life factors and iSC levels are shown for univariate multinomial regression analyses in Supplementary Table S1. Mothers not living with a partner, PSS ≥ 29 reported at 34 weeks, cesarean section, birth weight and mixed-fed infants were included in the multivariate multinomial logistic regression models, as p-values were ≤0.1, while not living with a partner, birth weight and mixed-fed infants remained statistically significantly associated with iSC in the final model (Table 3). Infants of mothers not living with a partner had lower odds of iSC levels ≥ 15.4 nmol/L than infants of mothers who were cohabitant or married. Higher birth weight was significantly associated with an iSC of ≥ 24.9 nmol/L, while mixed-fed infants were less likely to have high iSC levels at three months of age (Table 3).

4. Discussion

In this exploratory study with 1057 infants from the general population, perceived stress during pregnancy and postpartum was not associated with iSC levels at three months of age. Infants of mothers living without a partner had a lower odd of higher iSC levels, as did infants fed with a combination of bottle as well as breastfeeding, while higher birth weight increased the odds of higher iSC levels at three months of age.

4.1. Early Life Factors and Infant Saliva Cortisol

The lack of association between maternal perceived stress during pregnancy or post-partum and iSC levels is an unexpected finding and has, to our knowledge, previously not been seen in other studies. The infant cortisol stress reactivity score has previously been associated with maternal stress [16] and maternal distress in pregnancy [28]. In contrast to our results, Leung et al. [16] found no association between iSC and feeding, health indicators or sociodemographic factors. We did not measure stress reactivity in the infant in this study. This could be a possible explanation as to why our results differ.
Salivary cortisol in the mothers in mid-pregnancy was not significantly associated with iSC. In contrast to our results, previous studies have shown associations between mSC levels in pregnancy or postpartum and their iSC levels from six months of age [2,3]. In a study by Nazzari et al. [29], higher levels of maternal pregnancy cortisol were associated with increased cortisol response in infants with mothers less emotionally available. Whereas Irwin [30] showed that elevated maternal cortisol in pregnancy was associated with infant cortisol reactivity at 6- and 12 months of age. Our results suggest that the possibility of identifying an association could be dependent on the timespan between maternal/infant samples, as well as the number of samples taken at each timepoint. We did not measure maternal caregiving nor cortisol reactivity to stress in the infant in our study, this may partly explain why no association was detected in mSC and iSC. Altogether, our findings suggest that the relationship between PSS and SC levels in mothers and iSC levels is complex, and that potential stressors and the timing of sampling is sensitive and standardization is lacking.
The lower iSC levels among infants with a mother not living with a partner compared to infants with both parents at home, is, to our knowledge, a novel finding. In adolescents, parental depression has been associated with a diurnal SC pattern [31], but children of single parents, chronically ill parents or healthy parents have not shown any difference in diurnal SC pattern [31]. In other settings, mothers not living with a partner could indicate low socioeconomic status. The Family Life project [32] follows the development of children in low-income families in poor rural counties in North Carolina and Pennsylvania. Longitudinal data on infant between-person and within-person SC from seven months until two years of age showed that higher levels of resting iSC collected during the day were associated with lower infant attention [33]. In the PreventADALL study the majority of participants are Scandinavian and have a higher socioeconomic status than The Family Life project participants [32], which makes the two studies difficult to compare.
We observed that an increased birth weight was associated with higher levels of iSC at three months. There is, to our knowledge, no previous data on this association. Previous findings on infant birth weight and mSC morning and evening levels or depressive symptoms have been shown in Lundholm et al. [34]. They found an association between birth weight and symptoms of maternal depression in the mother in early pregnancy in the Swedish MAESTRO cohort. In the American MADRES [35] cohort they did not see any significant association between infant birth weight and maternal third trimester cortisol levels.
At three months of age, there was no significant difference in median iSC levels between boys and girls, which is in accordance with the study by Rolfsjord et al. [1], in six months-old infants. However, they found higher morning iSC values in girls at two years of age. In other studies, the results are conflicting [36], although a recent review [36] showed higher cortisol levels and a steeper decline over the day in cortisol among girls compared to boys in the majority of the studies. The same study also suggested that girls express less fluctuation than boys over the day [36].
In our study, mixed-fed infants had lower iSC levels than exclusively breastfed infants. The benefits of breastfeeding in both mothers and their infants are well documented and explored. Mothers exclusively breastfeeding their infants have shown lower SC levels postpartum than mothers with mixed-fed infants [37]. In our study, mothers not living with a partner did not differ from cohabitant or married mothers in breastfeeding status (results not presented). The suggested fluctuation in iSC levels during breastfeeding [3] could explain why we found lower iSC levels among the mixed-fed infants. In addition, mothers who breastfeed report less anxiety, negative mood, stress and show reduced SC levels compared to mothers with formula-fed infants [38]. Breastfeeding overall is high in the PreventADALL study, where 93.6% of the women breastfed their infant to some extent by three months [39]. The latter could possibly explain why we did not detect a correlation, as previously described by Jonas et al. [3], between SC levels in mothers and infants, but lower iSC levels in the mixed-fed infants. Jonas et al. [3] showed a positive correlation of iSC levels in breastfed infants and mSC levels during pregnancy and post-partum [3]. Their sampling method differs from ours, with saliva samples taken at several occasions before and after breastfeeding, which could further explain why no correlation was found with our sampling method.
At the three-month clinical visit in the PreventADALL study, many of the parents randomized to oil baths mentioned the bathing event as a positive experience. There was no significant difference in iSC levels between the intervention groups, but the lowest iSC values were found among boys in the intervention group of oil baths. A previous study has found that bathing the infant promotes parent–infant bonding [40], hence closeness to the mother and/or father. To capture the possible positive effect of this bonding in a bathing situation, a different, repeated iSC sampling procedure closer in time before and after the bath may be needed. Other approaches, e.g., qualitative methods, could also contribute to the knowledge on parent–infant bonding in bathing situations.
Infants with colic and abdominal pain showed no difference in iSC levels from infants without colic or abdominal pain in our study. Mostly, our participants’ saliva was sampled during the day, while colic most commonly debuts in the early hours of the night. White et al. [41] have previously described a blunted cortisol rhythm in infants with colic, but their overall cortisol levels in infants with colic did not differ from their controls. Although physical pain has been a suggested stressor in infants [11], colic and abdominal pain is a common stressful concern for parents [42]. Infants with abdominal pains and colic could perhaps affect maternal PSS.

4.2. Strengths and Limitations

The present study has several strengths. All samples were obtained in the home environment by a parent or guardian, providing a feasible way to collect saliva from a large number of infants, in contrast to collection e.g., plasma cortisol that requires a more comprehensive procedure. Furthermore, saliva sampling is unlikely to cause stress to the mother or infant [43]. All the iSC and mSC analyses were performed by trained personnel with long experience of this particular SC analysis from other cohorts (Forskningscentrum, Södersjukhuset, Stockholm, Sweden). Although the questions in the electronic questionnaires are not validated, the majority of questions are standard questions used in other birth cohort studies [19]. Furthermore, we followed our participants (mothers, mother–child pairs) from early pregnancy and onward. Our study included longitudinal data from pregnancy, at birth and by three months infant age. The obstetric outcomes were verified by reviewing the individual hospital medical charts (Oslo and Kalnes) and The Swedish Pregnancy Register.
The following limitations should be noted. The population in this exploratory study originated from the PreventADALL birth cohort, where the main objective focuses on allergic disease prevention and the development of non-communicable diseases. The proportion of participants with a heredity of allergic diseases could therefore be biased. Furthermore, we used one validated instrument to measure stress in the mothers. That makes the generalizability of this study limited. The sampling method used resulted in a large amount of missing saliva samples (1057/2131) and missing records of sampling time of the infant saliva due to the home-sampling procedure. All iSC were analysed without any consideration of sampling time and skewness. SC samples were not tested for blood contamination. Our participants were instructed to collect the saliva sampling in the morning, 30 min after the child’s or own awakening, preferably before breast- or bottle-feeding. We did not collect complementary information nor further investigate if the instructions to study protocol were followed. Our stress data were based on one validated instrument and it was collected through self-reported electronic questionnaires which could increase the risk of information bias. PSS has been translated but not validated into the Norwegian language. Several samples in our study were taken later in the morning, in the afternoon or had a missing sampling time. We did not see, nor could draw conclusions of, a cortisol circadian rhythm in our infant population, neither on a group level nor on an individual level as our study only generated one sample per infant. The intention was to include a general population in this study; however, socioeconomic status was higher among the infants’ families who provided a saliva sample than those who did not (not presented), and data on maternal depression- and anxiety-medication were not available for the mothers. The association between iSC in non-cohabitant mothers was based on a very limited number of individuals, thus might be sporous. Limited statistical power did not allow us to estimate these associations with sufficient precision. All analyses in this study were considered exploratory so no correction for multiple testing was performed. These findings are therefore explorative and need to be confirmed in other studies with similar sampling and settings.
Our results suggest that the possibility of identifying a correlation between PSS and iSC could be dependent on the timespan between maternal/infant samples as well as the number of samples taken at each timepoint.

5. Conclusions

In this exploratory study, maternal perceived stress in pregnancy and post-partum was not associated with iSC levels at three months of age. Early life factors which were significantly associated with iSC included increased birthweight with increased iSC levels at three months, while infants of mothers not living with a partner and mixed-fed infants had lower levels of iSC. Altogether, these results suggest that the relationship between PSS and mSC levels in mothers and early life factors of iSC levels in infants are complex.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/children9050623/s1. Figure S1: Infant saliva cortisol (nmol/L) median levels related to sampling time (n = 1057) over 24 h. Infant saliva cortisol values are given in median (blue large squares) and min-max (grey and orange small squares). MT=missing time of saliva sampling (n = 427).; Table S1: Univariate multinomial logistic regression model analysis of possible associations of factors in pregnancy, birth and early life and infant salivary cortisol at three months of age (n = 1057). Results are presented as Odds Ratio (OR), 95 % Confidence intervals (95% CI) and p-value (p). Univariate multinomial logistic reference category <5.50 nmol/L, n = 266).; Table S2: Mann–Whitney U-test (pairwise with reference category (ref)) of background factors in pregnancy, at birth and by three months infant age and differences in median infant saliva cortisol at three moths age. Number are presented as number (n), present (%) and p-value. Median saliva cortisol and inter quartile range (IQR). (n = 1057).; Table S3: Mann–Whitney U-test stratified for infant biological sex of median infant saliva cortisol at three months age and maternal background factors and early life factors. Boy (n = 543) and Girl (n = 514).; Table S4: T-test of background characteristics and early life factors of included infants with saliva cortisol (n = 1057) and infants from the original PreventADALL mother/child cohort without saliva cortisol (n = 1337); Table S5: Spearman non-parametric correlations between maternal cortisol at 18 gestational weeks and maternal perceived stress in pregnancy at 18-, 34 weeks, and three-months infant age. Groups represent all maternal saliva samples, morning sample (05.00–10.59), other sampling time (11.00–04.59) and missing sampling time. Results are presented as numbers (n), correlation coefficient (r) and p-value.

Author Contributions

Conceptualization, C.-A.O.M., Å.W.D., M.C.S., K.C.L.C., B.N. and C.S.; Formal analysis, C.-A.O.M. and Å.W.D.; Funding acquisition, E.B., G.H. (Gunilla Hedlin), K.C.L.C., B.N. and C.S.; Investigation, C.-A.O.M., Å.W.D. and F.B.; Methodology, M.C.S.; Software, R.V.; Supervision, M.C.S., K.C.L.C., H.O.S., B.N. and C.S.; Writing—original draft, C.-A.O.M. and Å.W.D.; Writing—review and editing, C.-A.O.M., Å.W.D., M.C.S., C.A., F.B., E.B., A.B., K.G., B.G., G.H. (Guttorm Haugen), G.H. (Gunilla Hedlin), C.M.J., K.C.L.C., E.M.R., L.-B.R., A.C.S., H.O.S., R.V., B.N. and C.S. All authors have read and agreed to the published version of the manuscript.

Funding

The following funders have contributed to this study: the Swedish Heart and Lung Foundation, Swedish Asthma and Allergy Association, Karolinska Institutet SFO-V, FoUU ME Neonatologi, The Stockholm County Council (ALF-project), the Swedish Order of Freemasons Foundation Barnhuset, Konsul Th. C Bergh Foundation, Hesselman Research Foundation, Vårdalstiftelsen, the Swedish Research Council, Drottning Silvias Jubileumsfond, Kerstin Hejdenbergs stipendium, The Research Fund of the Norwegian Asthma and Allergy Association.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and was approved by the Regional Committee in Norway (2014/518) and the Swedish Ethical Review Authority (2014/2242-31/4) and registered at clinicaltrial.gov NCT02449850 (https://www.clinicaltrials.gov/ct2/results?recrs=&cond=&term=PreventADALL&cntry=&state=&city=&dist= accessed date 27 February 2022).

Informed Consent Statement

Informed consent was obtained from all mothers at inclusion and from parent(s) at the birth of the infant.

Data Availability Statement

Participants of this study were not asked to consent for open access data from third parties.

Acknowledgments

We sincerely thank all participants in PreventADALL and all health personnel and collaborators working with PreventADALL in Norway and Sweden.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Rolfsjord, L.B.; Bakkeheim, E.; Berents, T.L.; Alm, J.; Skjerven, H.O.; Carlsen, K.-H.; Mowinckel, P.; Sjöbeck, A.-C.; Carlsen, K.C.L. Morning Salivary Cortisol in Young Children: Reference Values and the Effects of Age, Sex, and Acute Bronchiolitis. J. Pediatr. 2017, 184, 193–198.e3. [Google Scholar] [CrossRef] [Green Version]
  2. Stenius, F.; Theorell, T.; Lilja, G.; Scheynius, A.; Alm, J.; Lindblad, F. Comparisons between salivary cortisol levels in six-months-olds and their parents. Psychoneuroendocrinology 2008, 33, 352–359. [Google Scholar] [CrossRef]
  3. Jonas, W.; Bisceglia, R.; Meaney, M.J.; Dudin, A.; Fleming, A.S.; Steiner, M.; The MAVAN Research Team. The role of breastfeeding in the association between maternal and infant cortisol attunement in the first postpartum year. Acta Paediatr. 2018, 107, 1205–1217. [Google Scholar] [CrossRef]
  4. Field, T.; Diego, M.; Hernandez-Reif, M.; Vera, Y.; Gil, K.; Schanberg, S.; Kuhn, C.; Gonzalez-Garcia, A. Prenatal Maternal Biochemistry Predicts Neonatal Biochemistry. Int. J. Neurosci. 2004, 114, 933–945. [Google Scholar] [CrossRef]
  5. Spratt, E.G.; Marsh, C.; Wahlquist, A.E.; Papa, C.E.; Nietert, P.J.; Brady, K.T.; Herbert, T.L.; Wagner, C. Biologic effects of stress and bonding in mother-infant pairs. Int. J. Psychiatry Med. 2016, 51, 246–257. [Google Scholar] [CrossRef] [Green Version]
  6. Wilhelm, I.; Born, J.; Kudielka, B.M.; Schlotz, W.; Wüst, S. Is the cortisol awakening rise a response to awakening? Psychoneuroendocrinology 2007, 32, 358–366. [Google Scholar] [CrossRef]
  7. Ivars, K.; Nelson, N.; Theodorsson, A.; Theodorsson, E.; Ström, J.O.; Morelius, E. Development of Salivary Cortisol Circadian Rhythm and Reference Intervals in Full-Term Infants. PLoS ONE 2015, 10, e0129502. [Google Scholar] [CrossRef]
  8. Vittner, D.; McGrath, J.; Robinson, J.; Lawhon, G.; Cusson, R.; Eisenfeld, L.; Walsh, S.; Young, E.; Cong, X. Increase in Oxytocin From Skin-to-Skin Contact Enhances Development of Parent–Infant Relationship. Biol. Res. Nurs. 2018, 20, 54–62. [Google Scholar] [CrossRef] [Green Version]
  9. Luecken, L.J.; Crnic, K.A.; Gonzales, N.A.; Winstone, L.K.; Somers, J.A. Mother-infant dyadic dysregulation and postpartum depressive symptoms in low-income Mexican-origin women. Biol. Psychol. 2019, 147, 107614. [Google Scholar] [CrossRef]
  10. Puhakka, I.J.; Peltola, M.J. Salivary cortisol reactivity to psychological stressors in infancy: A meta-analysis. Psychoneuroendocrinology 2020, 115, 104603. [Google Scholar] [CrossRef] [Green Version]
  11. Jansen, J.; Beijers, R.; Riksen-Walraven, M.; de Weerth, C. Cortisol reactivity in young infants. Psychoneuroendocrinology 2010, 35, 329–338. [Google Scholar] [CrossRef] [PubMed]
  12. de Kruijff, I.; Tromp, E.; Lambregtse-van den Berg, M.P.; Vlieger, A.M.; Benninga, M.A.; de Rijke, Y.B.; van den Akker, E.L. Parental Stress and Scalp Hair Cortisol in Excessively Crying Infants: A Case Control Study. Children 2021, 8, 662. [Google Scholar] [CrossRef]
  13. Despriee, Å.W.; Mägi, C.O.; Småstuen, M.C.; Glavin, K.; Nordhagen, L.; Jonassen, C.M.; Rehbinder, E.M.; Nordlund, B.; Söderhäll, C.; Carlsen, K.L.; et al. Prevalence and perinatal risk factors of parent-reported colic, abdominal pain and other pain or discomforts in infants until 3 months of age—A prospective cohort study in PreventADALL. J. Clin. Nurs. 2021, 1–14. [Google Scholar] [CrossRef]
  14. Davis, E.P.; Glynn, L.M.; Waffarn, F.; Sandman, C.A. Prenatal maternal stress programs infant stress regulation. J. Child Psychol. Psychiatry 2011, 52, 119–129. [Google Scholar] [CrossRef] [Green Version]
  15. Lutkiewicz, K.; Bieleninik, Ł.; Cieślak, M.; Bidzan, M. Maternal–Infant Bonding and Its Relationships with Maternal Depressive Symptoms, Stress and Anxiety in the Early Postpartum Period in a Polish Sample. Int. J. Environ. Res. Public Health 2020, 17, 5427. [Google Scholar] [CrossRef]
  16. Leung, E.; Tasker, S.L.; Atkinson, L.; Vaillancourt, T.; Schulkin, J.; Schmidt, L.A. Perceived Maternal Stress During Pregnancy and Its Relation to Infant Stress Reactivity at 2 Days and 10 Months of Postnatal Life. Clin. Pediatr. 2010, 49, 158–165. [Google Scholar] [CrossRef]
  17. Mägi, C.A.O.; Bäcklund, A.B.; Carlsen, K.L.; Almqvist, C.; Carlsen, K.H.; Granum, B.; Haugen, G.; Hilde, K.; Lødrup Carlsen, O.C.; Jonassen, C.M.; et al. Allergic disease and risk of stress in pregnant women: A PreventADALL study. ERJ Open Res. 2020, 6, 00175-2020. [Google Scholar]
  18. Carlsen, L.K.C.; Rehbinder, E.M.; Skjerven, H.O.; Carlsen, M.H.; Fatnes, T.A.; Fugelli, P.; Granum, B.; Haugen, G.; Hedlin, G.; Jonassen, C.M. Preventing Atopic Dermatitis and ALLergies in Children-the PreventADALL study. Allergy 2018, 73, 2063–2070. [Google Scholar] [CrossRef]
  19. Hohmann, C.; Pinart, M.; Tischer, C.; Gehring, U.; Heinrich, J.; Kull, I.; Melén, E.; Smit, H.A.; Torrent, M.; Wijga, A.H.; et al. The development of the MeDALL Core Questionnaires for a harmonized follow-up assessment of eleven European birth cohorts on asthma and allergies. Int. Arch. Allergy Immunol. 2014, 163, 215–224. [Google Scholar] [CrossRef] [Green Version]
  20. Magnus, P.; Irgens, L.M.; Haug, K.; Nystad, W.; Skjærven, R.; Stoltenberg, C. Cohort profile: The Norwegian Mother and Child Cohort Study (MoBa). Int. J. Epidemiol. 2006, 35, 1146–1150. [Google Scholar] [CrossRef] [Green Version]
  21. Wickman, M.; Kull, I.; Pershagen, G.; Nordvall, S.L. The BAMSE Project: Presentation of a prospective longitudinal birth cohort study. Pediatr. Allergy Immunol. 2002, 13, 11–13. [Google Scholar] [CrossRef] [PubMed]
  22. Clements, A.D.; Parker, C.R. The relationship between salivary cortisol concentrations in frozen versus mailedsamples. Psychoneuroendocrinology 1998, 23, 613–616. [Google Scholar] [CrossRef]
  23. Garde, A.H.; Hansen, A.M. Long-term stability of salivary cortisol. Scand. J. Clin. Lab. Investig. 2005, 65, 433–436. [Google Scholar] [CrossRef] [PubMed]
  24. Hansen, Å.M.; Garde, A.H.; Christensen, J.M.; Eller, N.H.; Netterstrøm, B. Evaluation of a radioimmunoassay and establishment of a reference interval for salivary cortisol in healthy subjects in Denmark. Scand. J. Clin. Lab. Investig. 2003, 63, 303–310. [Google Scholar] [CrossRef]
  25. Cohen, S.; Kamarck, T.; Mermelstein, R. A global measure of perceived stress. J. Health Soc. Behav. 1983, 24, 385–396. [Google Scholar] [CrossRef]
  26. Eskin, M.; Parr, D. Introducing a Swedish Version of an Instrument Measuring Mental Stress; Reports from the Department of Psychology, Stockholm University 0345-0139:813; Department of Psychology, Stockholm University: Stockholm, Sweden, 1996. [Google Scholar]
  27. Skjerven, H.O.; Rehbinder, E.M.; Vettukattil, R.; LeBlanc, M.; Granum, B.; Haugen, G.; Hedlin, G.; Landrø, L.; Marsland, B.J.; Rudi, K.; et al. Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): A factorial, multicentre, cluster-randomised trial. Lancet 2020, 395, 951–961. [Google Scholar] [CrossRef]
  28. McLean, M.A.; Simcock, G.; Elgbeili, G.; Laplante, D.P.; Kildea, S.; Hurrion, E.; Lequertier, B.; Cobham, V.E.; King, S. Disaster-related prenatal maternal stress, and childhood HPA-axis regulation and anxiety: The QF2011 Queensland Flood Study. Psychoneuroendocrinology 2020, 118, 104716. [Google Scholar] [CrossRef]
  29. Nazzari, S.; Fearon, P.; Rice, F.; Molteni, M.; Frigerio, A. Maternal caregiving moderates the impact of antenatal maternal cortisol on infant stress regulation. J. Child Psychol. Psychiatry. 2021. [Google Scholar] [CrossRef]
  30. Irwin, J.L.; Meyering, A.L.; Peterson, G.; Glynn, L.M.; Sandman, C.A.; Hicks, L.M.; Davis, E.P. Maternal prenatal cortisol programs the infant hypothalamic–pituitary–adrenal axis. Psychoneuroendocrinology 2020, 125, 105106. [Google Scholar] [CrossRef]
  31. Sieh, D.S.; Visser-Meily, J.M.; Oort, F.; Meijer, A.M. The diurnal salivary cortisol pattern of adolescents from families with single, ill and healthy parents. J. Psychosom. Res. 2012, 72, 288–292. [Google Scholar] [CrossRef] [Green Version]
  32. Vernon-Feagans, L.; Cox, M.I. Poverty, Rurality, Parenting, and Risk: An Introduction: Poverty, Rurality, Parenting, and Risk. Monogr. Soc. Res. Child Dev. 2013, 8, 1–23. [Google Scholar] [CrossRef]
  33. Brandes-Aitken, A.; Braren, S.; Vogel, S.C.; Perry, R.E.; Brito, N.H.; Blair, C. Within-person changes in basal cortisol and caregiving modulate executive attention across infancy. Dev. Psychopathol. N. Y. USA 2021, 1–14. [Google Scholar] [CrossRef]
  34. Lundholm, C.; Rejnö, G.; Brew, B.; Smew, A.I.; Saltvedt, S.; Almqvist, C. Associations between maternal distress, cortisol levels and perinatal outcomes. Psychosom. Med. 2022, 84, 288–296. [Google Scholar] [CrossRef] [PubMed]
  35. Peterson, A.; Toledo-Corral, C.M.; Chavez, T.; Naya, C.; Johnson, M.; Eckel, S.; Lerner, D.; Grubbs, B.; Farzan, S.; Dunton, G.; et al. Prenatal Maternal Cortisol Levels and Infant Birth Weight in a Predominately Low-Income Hispanic Cohort. Int. J. Environ. Res. Public Health 2020, 17, 6896. [Google Scholar] [CrossRef] [PubMed]
  36. Hollanders, J.J.; van der Voorn, B.; Rotteveel, J.; Finken, M.J.J. Is HPA axis reactivity in childhood gender-specific? A systematic review. Biol. Sex Differ. 2017, 8, 23. [Google Scholar] [CrossRef] [PubMed]
  37. Mizuhata, K.; Taniguchi, H.; Shimada, M.; Hikita, N.; Morokuma, S. Effects of Breastfeeding on Stress Measured by Saliva Cortisol Level and Perceived Stress. Asian Pac. Isl. Nurs. J. 2020, 5, 128–138. [Google Scholar] [CrossRef]
  38. Krol, K.M.; Grossmann, T. Psychological effects of breastfeeding on children and mothers. Bundesgesundheitsblatt Gesundh. Gesundh. 2018, 61, 977–985. [Google Scholar] [CrossRef] [Green Version]
  39. Nordhagen, L.S.; Kreyberg, I.; Bains, K.E.S.; Carlsen, K.; Glavin, K.; Skjerven, H.O.; Småstuen, M.C.; Hilde, K.; Nordlund, B.; Vettukattil, R.; et al. Maternal use of nicotine products and breastfeeding 3 months postpartum. Acta Paediatr. 2020, 109, 2594–2603. [Google Scholar] [CrossRef]
  40. Blume-Peytavi, U.; Cork, M.; Faergemann, J.; Szczapa, J.; Vanaclocha, F.; Gelmetti, C. Bathing and cleansing in newborns from day 1 to first year of life: Recommendations from a European round table meeting. J. Eur. Acad. Dermatol. Venereol. 2009, 23, 751–759. [Google Scholar] [CrossRef]
  41. White, B.P.; Gunnar, M.R.; Larson, M.C.; Donzella, B.; Barr, R.G. Behavioral and Physiological Responsivity, Sleep, and Patterns of Daily Cortisol Production in Infants with and without Colic. Annu. Prog. Child Psychiatry Child Dev. 2002, 71, 862–877. [Google Scholar] [CrossRef]
  42. Barr, R.G. Preventing abusive head trauma resulting from a failure of normal interaction between infants and their caregivers. Proc. Natl. Acad. Sci. USA 2012, 109, 17294–17301. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Kirschbaum, C.; Hellhammer, D.H. Salivary cortisol in psychoneuroendocrine research: Recent developments and applications. Psychoneuroendocrinology 1994, 19, 313–333. [Google Scholar] [CrossRef]
Children 09 00623 g001 550
Figure 1. Flowchart of included mothers and infants.
Figure 1. Flowchart of included mothers and infants.
Children 09 00623 g001
Children 09 00623 g002 550
Figure 2. Infant saliva cortisol levels related to sampling time (n = 1057). Values are given in median (nmol/L), blue large squares) and inter quartile range (25th—75th percentile).
Figure 2. Infant saliva cortisol levels related to sampling time (n = 1057). Values are given in median (nmol/L), blue large squares) and inter quartile range (25th—75th percentile).
Children 09 00623 g002
Table
Table 1. Maternal, neonatal and infant characteristics of the infants with saliva cortisol at three months of age (n = 1057) and for those that did not provide saliva samples (not included n = 1337). Values are presented as numbers, percent (%), median iSC, interquartile range (IQR).
Table 1. Maternal, neonatal and infant characteristics of the infants with saliva cortisol at three months of age (n = 1057) and for those that did not provide saliva samples (not included n = 1337). Values are presented as numbers, percent (%), median iSC, interquartile range (IQR).
Study Cohort (n = 1057)Not Included (n = 1337)
n (%)Median (IQR)n (%)Median (IQR)
Gestational age, birth (weeks)1052 (99.5)40.14 (1.71)1336 (99.9)40.29 (1.71)
Birth weight (grams)953 (90.2)3550 (646)1332 (99.6)3555 (620)
Age at SC sampling (weeks)663 (62.7)14.00 (2.0)674 (50.4)14.00 (4.0)
Saliva cortisol, infant (nmol/L)1057 (100)15.30 (15.35)1337(100)Na *
Boys543 (51.4)15.50 (15.9)712 (53.3)Na *
Girls514 (48.6)15.10 (14.58)625 (46.7)Na *
Maternal age (years)1057 (100)32 (6.00)1337(100)32 (6.00)
Saliva cortisol, maternal 18 w (nmol/L)531 (50.2)29.60 (14.30)190 (14.2)29.4 (13.35)
Perceived stress scale
Pregnancy, 18 weeks1002 (94.7)21.00 (9.00)1169 (87.4)21.00 (10.00)
Pregnancy, 34 weeks1016 (96.1)20.00 (10.00)1219 (91.2)20.00 (9.00)
3-month post-partum933 (88.2)18.00 (10.00)919 (68.7)18.00 (9.00)
n (%)median (IQR)n (%)median (IQR)
Marital status, n (%) Married430 (42.9)15.35 (16.0)465 (39.8)Na *
Cohabitant549 (54.8)15.80 (15.7)668 (57.1)Na *
Not living with a partner23 (2.3)7.70 (10.2)36 (3.1))Na *
Education n (%) High school106 (10.6)17.50 (17.25)133 (11.5)Na *
≤4 years University318 (31.8)15.75 (16.4)133 (32.0)Na *
>4 years University, PhD575 (57.6))14.90 (13.9)656 (56.5)Na *
* not applicable.
Table
Table 2. Spearman non-parametric correlations between infant cortisol at three months and maternal perceived stress in pregnancy at 18-, 34 weeks, and at three months infant age and maternal cortisol (18 w). Groups represent infants with All infant saliva cortisol (All iSC) regardless of sampling time (n = 1057); Morning sample (05–10:59, n = 551); Other sampling time from 11 am (until 04:59 pm, n = 79); Missing sampling time (no stated time of sampling, n = 427).
Table 2. Spearman non-parametric correlations between infant cortisol at three months and maternal perceived stress in pregnancy at 18-, 34 weeks, and at three months infant age and maternal cortisol (18 w). Groups represent infants with All infant saliva cortisol (All iSC) regardless of sampling time (n = 1057); Morning sample (05–10:59, n = 551); Other sampling time from 11 am (until 04:59 pm, n = 79); Missing sampling time (no stated time of sampling, n = 427).
Infant Saliva Cortisol Samples
AllMorning Sample Other Sampling TimeMissing Sampling Time
nr (p-Value)nr (p-Value)nr (p-Value)nr (p-Value)
PSS 18 weeks10020.00 (0.99)516−0.07 (0.10)70−0.06 (0.65)4160.06 (0.26)
PSS 34 weeks1016−0.01 (0.66)533−0.06 (0.14)760.00 (0.96)4070.05 (0.28)
PSS 3-month933−0.04 (0.25)496−0.07 (0.13)67−0.03 (0.83)370−0.00 (0.98)
Maternal cortisol 18 w5310.05 (0.29)3690.07 (0.18)510.17 (0.23)1110.07 (0.47)
Table
Table 3. Multivariate multinomial logistic regression model analysis of possible associations of early life factors (identified in univariate multinomial regression, p-value < 0.1) and salivary cortisol in 1057 infants at three months of age.
Table 3. Multivariate multinomial logistic regression model analysis of possible associations of early life factors (identified in univariate multinomial regression, p-value < 0.1) and salivary cortisol in 1057 infants at three months of age.
Multivariate Analysis <0.1 from Univariate (Reference Category <5.50 nmol/L, n = 266)
Saliva Cortisol 5.51–15.35 nmol/L (n = 263)Saliva Cortisol 15.36–24.93 nmol/L (n = 265)Saliva Cortisol ≥ 24.94 nmol/L (n = 263)
OR95% CIpOR95% CIpOR95% CIp
Birth weight *1.041.00–1.080.091.030.99–1.070.121.051.01–1.090.02
Cesarean section0.640.37–1.090.100.970.59–1.590.911.110.68–1.810.67
Vaginal birth (ref.)1.00 1.00 1.00
Not living with partner0.480.23–1.010.050.320.14–0.730.010.460.22–0.980.04
Married/cohabitant (ref.)1.00 1.00 1.00
Mixed fed1.020.69–1.500.930.720.50–1.060.090.600.41–0.880.01
Breastfed only (ref.)1.00 1.00 1.00
High PSS 34 w0.980.55–1.720.931.430.84–2.450.190.810.44–1.470.48
Low stress < 29 (ref.)1.00 1.00 1.00
* Represents increase in 100 g.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Olsson Mägi, C.-A.; Wik Despriee, Å.; Småstuen, M.C.; Almqvist, C.; Bahram, F.; Bakkeheim, E.; Bjerg, A.; Glavin, K.; Granum, B.; Haugen, G.; et al. Maternal Stress, Early Life Factors and Infant Salivary Cortisol Levels. Children 2022, 9, 623. https://doi.org/10.3390/children9050623

AMA Style

Olsson Mägi C-A, Wik Despriee Å, Småstuen MC, Almqvist C, Bahram F, Bakkeheim E, Bjerg A, Glavin K, Granum B, Haugen G, et al. Maternal Stress, Early Life Factors and Infant Salivary Cortisol Levels. Children. 2022; 9(5):623. https://doi.org/10.3390/children9050623

Chicago/Turabian Style

Olsson Mägi, Caroline-Aleksi, Åshild Wik Despriee, Milada Cvancarova Småstuen, Catarina Almqvist, Fuad Bahram, Egil Bakkeheim, Anders Bjerg, Kari Glavin, Berit Granum, Guttorm Haugen, and et al. 2022. "Maternal Stress, Early Life Factors and Infant Salivary Cortisol Levels" Children 9, no. 5: 623. https://doi.org/10.3390/children9050623

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop